[3]
Kulkarni AS, Aloorkar NH, Mane MS, Gaja JB. Liquisolid systems: A review. Int J Pharm Sci Nanotechnol 2010; 3: 795-802.
[6]
Balaji A, Shankar MS, Kavitha B. Liquisolid technology- A latest review. Int J App Pharm 2014; 6(1): 11-9.
[7]
Phoke SV, Hatkar AD, Jaybhaye SS. Improvement of solubility and dissolution by liquisolid compact. J Pharma Care Health Sys 2012; 9(1): 1-6.
[8]
Spiras S, Wang T, Grover R. Effect of powder substrate on dissolution properties of methylclothiazide liqui-solid compacts. Drug Dev Ind Pharm 1999; 25: 63-168.
[11]
Gavali SM, Pacharane SS, Sankpal SV, Jadhav KR, Kadam VJ. Liquisolid compact: A new technique for enhancement of drug dissolution. Int J Res Pharm Chem 2011; 1: 705-13.
[12]
Nagabandi VK, Ramarao T, Jayaveera KN. Liquisolid compacts: A novel approach to enhance bioavailability of poorly soluble drugs. Int J Pharm Biol Sci 2011; 1: 89-102.
[14]
Sirisha VNL, Sruthi B, Namrata M, et al. A review on liquid solid compacts. Int J Pharm Phytopharmacol Res 2012; 2(2): 116-21.
[15]
Sai PDL, Sivaiah KV, Bonthagarala B, Rao PV. Review on liquisolid compact technology. World J Pharm Res 2014; 4: 293-306.
[17]
Rowe RC, Sheskey PJ, Quinn M. Handbook of Pharmaceutical Excipients. (6th ed.). Stuttgart, Germany: Deutscher Apotheker Verlag 2006; p. 918.
[18]
Vajir S, Sahu V, Bakde GN. Effect of dissolution rate by liquisolid compact approach: An overview. Int J Pharm Chem Sci 2012; 1(3): 368-87.
[19]
Karmarkar AB, Gonjari ID, Hosmani AH, Dhabale PN, Bhise SB. Dissolution rate enhancement of fenofibrate using liquisolid tablet technique. Lat Am J Pharm 2009; 28: 219-25.
[20]
Syed IA, Pavani E. The liquisolid technique: Based drug delivery system. Int J Pharm Sci Drug Res 2012; 4: 88-96.
[22]
Sharma S. The role of excipients in liquisolid technology. CGC Int J Contemp Technol 2022; 4(2): 296-7.
[24]
Phoke SV, Hatkar AD, Borade AS, Rawat SS, Vyas GV. Review on improvement of solubility and dissolution by liquisolid compact. Int Res J Mod Eng Technol Sci 2022; 4(12): 1083-91.
[27]
Yadav VB, Yadav AV. Improvement of solubility and dissolution of indomethacin by liquisolid and compaction granulation technique. J Pharm Sci Res 2009; 1: 44-51.
[29]
Bindu MB, Kusum B, Banji D. Novel strategies for poorly water soluble drugs. Int J Pharm Sci Rev Res 2010; 4(3): 1-5.
[30]
Patel U, Modi D, Shah D, Shah C, Patel H. Review on liquisolid compacts: A novel approach to enhance solubility of poorly soluble drugs. J Pharm Sci Bioscientific Res 2016; 6(5): 706-12.
[33]
Sharma A, Jain CP. Techniques to enhance solubility of poorly soluble drugs: A review. J Glob Pharma Technol 2010; 2: 18-28.
[39]
Patel BB, Shah C. Recent research on liquisolid technology for solubility enhancement-a review. Int J Adv Pharm 2016; 5: 1-7.
[40]
Chaumeil JC. Micronisation, a method of improving the bioavailability of poorly soluble drugs, methods and findings in experimental and clinical pharmacology. Methods Find Exp Clin Pharmacol 2000; 10: 17-28.
[42]
Rawat A, Verma S, Kaul M, Saini S. Solid dispersion: A strategy for solubility enhancement. Int J Pharm Tech 2011; 3(2): 1062-99.
[48]
Kadam SV, Shinkar DM, Saudagar RB. Review on solubility enhancement techniques. IJPBS 2013; 3(3): 462-75.
[49]
Jagtap S, Magdum C, Jadge D, Jagtap R. Solubility enhancement technique: A review. J Pharmaceut Sci Res 2018; 10(9): 2205-11.
[53]
Khan I, Khan ML, Khan U. Liquisolid technology: An emerging and advance technique for enhancing solubilization. PharmaTutor 2014; 2(6): 31-41.
[54]
Hasanandini J, Parthibans S, Vilkeuwari A. Dissolution enhancement technique of poorly soluble drug by liquisolid compact. Int J Res Pharm Nanol Sci 2014; 3: 298-304.
[55]
Manpreet K, Rajni B, Sandeep A. Liquisolid technology: A review. Int J Adv Pharm Sci 2013; 4: 1-5.
[57]
Anjan KM, Sastry GM, Ranjit PS, Murthy PN, Narahari NP. Liquisolid technique: A novel approach in pharmaceutical formulation de-velopment. J Chem Pharm Res 2014; 6: 529-43.
[61]
Mohan D, Chivate AN. Formulation and evaluation of liquisolid compact on NSAID naproxen. Res J Pharm Technol 2014; 7: 284-9.
[62]
Sahoo PK, Dash S, Sahoo AC, Mishra B. Dissolution enhancement of prednisolone using liquisolid compacts. Int J Pharm Sci Res 2021; 13(12): 666-72.
[63]
Aher SS, Rane TP, Saudagar RB. Formulation and evaluation of lercanidipine hydrochloride by liquisolid technique. IJPRR 2016; 7: 35-52.
[65]
Kalbhor M, Bhosale A, Patil R, Kakade S. Formulation and evaluation of telmisartan liquisolid compact tablets. Human J 2017; 9(4): 152-82.
[69]
Patel G, Pandya D, Gandhi P, Parikh R. Formulation of modified liquisolid compact for dissolution enhancement of raloxifene hydrochloride. Pharm Technol 2021; 45(7): 48-52.
[76]
Bhairav BA, Jadhav MS, Saudagar RB. Formulation and evaluation of liquisolid tablet of felodipine. World J Pharm Pharm Sci 2016; 5(7): 1670-85.
[78]
Kondawar M, Varne B. Enhancement of dissolution properties of candesartan using liquisolid technique. Int J Adv Pharm Res 2013; 4: 2503-13.
[79]
Saraswathi B, Rajendar M. Liquisolid technology for enhancing the dissolution profile of irbesartan by using different non volatile sol-vents and carrier materials. J Pharm Pharm Sci 2014; 3(10): 839-54.
[80]
Pardhi DM, Shivhare UD, Mathur VB, Bhusari KP. Liquisolid technique for enhancement of dissolution properties of carvedilol. Pharm Lett 2010; 2: 412-27.
[94]
Thakur N, Khokra SL, Sharma D, Thakur NS, Purohit R, Arya V. A review on pharmaceutical application of liquisolid technique. Am J Pharmtech Res 2011; 1: 1-18.
[104]
Spireas S, Bolton S M. Liquisolid systems and methods of preparing same. US6096337A, 2000.
[105]
Wagner K G, Lamprecht A, Kroma A K, Grisic D, Denninger A, Becker T. Liquisolid pharmaceutical formulation and process for manufacturing. WO2021219817A1, 2021.
[106]
Monsuur F H. Porous silica gel as a carrier for liquid technologies. US20150366805A1, 2015.
[107]
Wolf C, Krekeler A, Sedlmayr M. Selexipag formulation in liquisolid systems. WO2018109158A1, 2018.
[108]
El–Say K M, Alotaibi F O, Alhakamy N A, Omar AM. Liquisolid tablet containing combined dose of tadalafil and dapoxetine. US10744137B1, 2020.
[109]
Wagner K G, Kroma A K, Horaf A, et al. Solid and liquisolid formulations of Corallopyronin A. WO2021219808A1, 2021.
[110]
Singh S K, Kumar R, Gulati M, et al. Novel liquisolid composition of fisetin. AU2021106234A4, 2021.
[111]
Humberto G F, Bianca R P, Diva S, et al. Liquisolid multiparticulate systems for oral administration, process of obtaining the same and their uses. BR102016015553A2, 2018.
[112]
Spireas S. Methods of treatment with metaxalone comprising nonvolatile liquids. US20130245083A, 2013.
[113]
Chaurasiya A, Jagwani A, Jain V, et al. Fast-release solid oral celecoxib composition for the treatment of acute pain. DE202022104280U1, 2022.